Results 51 to 60 of about 9,543,544 (289)

Graves' Disease.

open access: yesNew England Journal of Medicine, 2016
Graves’ disease was first recognized in the 19th century as a syndrome comprising an enlarged and overactive thyroid gland, an accelerated heart rate, and ocular abnormalities (Fig. 1).
Terry J Smith, Laszlo Hegedüs
semanticscholar   +1 more source

Assessing the spatio-temporal spread of COVID-19 via compartmental models with diffusion in Italy, USA, and Brazil [PDF]

open access: yesarXiv, 2021
The outbreak of COVID-19 in 2020 has led to a surge in interest in the mathematical modeling of infectious diseases. Such models are usually defined as compartmental models, in which the population under study is divided into compartments based on qualitative characteristics, with different assumptions about the nature and rate of transfer across ...
arxiv  

A simple ionospheric correction method for radar-based space surveillance systems, with performance assessment on GRAVES data [PDF]

open access: yes, 2022
Ionospheric effects degrade the quality of radar data, which are critical for the precision of the satellite ephemeris produced by space surveillance systems; this degradation is especially noticeable for radars such as GRAVES that operate in the very high frequency range.
arxiv   +1 more source

Molecular Alteration Analysis of Human Gut Microbial Composition in Graves' disease Patients

open access: yesInternational Journal on Biological Sciences, 2018
The gut microbial association with host co-existence is critical for body homeostasis and pathogenicity. Graves' disease (GD) is an autoimmune disease manifested with hyperthyroidism and ophthalmopathy.
H. M. Ishaq   +8 more
semanticscholar   +1 more source

The role of Graves’ disease in the development of thyroid nodules and thyroid cancer

open access: yesEuropean Thyroid Journal, 2023
Aim: The prevalence of thyroid nodules and the risk of thyroid cancer in patients with Graves’ disease is uncertain. We aimed to evaluate the prevalence of thyroid nodules and cancer in patients with Graves’ disease.
Marta Nascimento Soares   +4 more
doaj   +1 more source

Graves’ Disease Induced by Immune Checkpoint Inhibitors: A Case Report and Review of the Literature

open access: yesEuropean Thyroid Journal, 2019
Introduction: In the last few years, immune checkpoint inhibitors (ICPis) have become a common treatment of cancer. ICPis are associated with peculiar immune side effects, termed immune-related adverse events (irAEs). Thyroid disfunction is a common irAE,
A. Brancatella   +8 more
semanticscholar   +1 more source

Co-occurrence of autoimmune thyroid disease in a multiple sclerosis cohort [PDF]

open access: yes, 2005
BACKGROUND: Multiple sclerosis (MS), Hashimoto's disease and Graves' disease are autoimmune diseases that may share similar pathogenic mechanisms. The co-occurrence rates and demographic characteristics of Graves' disease and Hashimoto's disease (HT) in ...
Joyce, C   +3 more
core   +2 more sources

Comparison of Thyroid Size-Specific Radioiodine Dose and New Modified Dose Calculation in the Treatment of Graves’ Disease [PDF]

open access: yesEndocrinology and Metabolism
Background Previous studies of fixed-dose radioiodine therapy (RIT) for Graves’ disease (GD) have utilized a variety of techniques and reported differing success rates.
Alisara Wongsuttilert   +3 more
doaj   +1 more source

Unilateral Graves’ Orbitopathy in a patient with Marine-Lenhart Syndrome: A case report [PDF]

open access: yes
Thyroid eye disease (TED) is the most common symptoms of Graves’ disease. This condition commonly manifests bilaterally and symmetrically. The most prominent symptoms are lid retraction, exophthalmos, and diplopia.
Al Farqani, Ahmed   +6 more
core   +2 more sources

An uncommon case of Marine-Lenhart syndrome [PDF]

open access: yes, 2014
The term Marine-Lenhart syndrome describes the association between Graves' disease and autonomously functioning thyroid nodules (AFTN), such as toxic adenoma or toxic multinodular goiter.
Alfredo Campennì   +6 more
core   +2 more sources

Home - About - Disclaimer - Privacy